activities in older to develop new drugs along with growing awareness pertaining to
availability of these treatments have raised considerable demand for GI drugs. Apart
from this, technological reforms in the treatment offers superior outputs and expected
to contribute significantly in the forthcoming years. The exact cause of GI related
disorders are still unknown, due to which cure for these disorders is not available. This
may hamper global growth of gastrointestinal drugs market by inviting various
complications.
Global gastrointestinal market will have numerous growth opportunities during the
forecasted period on account of technological advancement, significant unmet need for
novel, safe and effective treatments and increasing geriatric population that highly
susceptible to the gi disorders.
Segments Covered:
The report segments the global gastrointestinal drugs market by drug category, by route
of administration, by disease type, by end user and by region. The market size of each
segment has been provided in terms of value (USD). Market segmentation based on
type of drugs category includes acid neutralizers, antidiarrheal and laxatives, antiemetic,
anti-inflammatory, and others. Wherein acid neutralizer’s further sub segmented into
antacids, H2 antagonists, and proton pump inhibitor. On the basis of route of
administration global market has been segmented into oral, parenteral, and rectal.